📋 FDA Reference

Synox SX 53-bp SX 60-bp SX 45-jbp SX 53-jbp Models 120 444 119 684 120 438 and 120 143

Biotronik AG

Contact a rep Compare similar devices

Summary: The Synox SX models by Biotronik are FDA-cleared inferior vena cava (IVC) filters used to prevent pulmonary embolism. They are typically utilized by interventional radiologists and vascular surgeons.

FDA Clearance Information

Pathway ? 510(k)
Number ? K980869 ↗
Decision Date ? September 10, 1998
Product Code ? DTB
Device Class ? Class 3
Evidence ? 0 studies

The Synox SX models were cleared through the FDA 510(k) pathway on September 10, 1998. Manufactured by Biotronik, these devices are classified as Class III under product code DTB.

What It Is

The Synox SX models are a series of inferior vena cava (IVC) filters designed to prevent blood clots from traveling to the lungs, thereby reducing the risk of pulmonary embolism. These devices are implanted into the inferior vena cava, a large vein carrying deoxygenated blood from the lower body to the heart. The filter captures clots while allowing normal blood flow, offering a protective measure for patients at risk of thromboembolic events.

FDA-Cleared Indications

  • Prevention of pulmonary embolism by placement of an inferior vena cava filter.
  • Use in patients at risk for pulmonary embolism when anticoagulant therapy is contraindicated or cannot be used.

Clinical Applications

  • Placement in the inferior vena cava to reduce the risk that venous thromboemboli will reach the lungs.
  • Use when anticoagulation therapy is medically contraindicated.
  • Use as part of IVC filter treatment for patients at risk of pulmonary embolism from lower-extremity or pelvic venous thromboembolism.

Reported off-label uses

  • Placement in selected patients with recurrent pulmonary embolism or venous thromboembolism despite therapeutic anticoagulation; this use should be evaluated individually and is not a substitute for treating the underlying clot.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Practical Considerations

  • The listed models include different filter configurations and sizes; the selected model must be matched to the patient's IVC diameter and anatomy according to the device labeling.
  • Placement is typically performed through venous access, commonly the femoral or internal jugular vein, using fluoroscopic or other appropriate imaging guidance.
  • The device labeling and current institutional policy should be reviewed for retrieval capability, because the long-term management of an implanted filter depends on its specific design and clinical circumstances.
  • MRI safety and imaging conditions should be confirmed from the original manufacturer labeling before MRI. Do not assume that an older filter is MR Safe or MR Conditional without documentation.
  • Potential complications include filter migration, malposition, thrombosis or occlusion of the IVC, perforation, fracture, and recurrent venous thromboembolism; anticoagulation remains the preferred treatment when it can be safely given.

Procedures that use this device

Frequently Asked Questions

What is Synox SX used for?

The Synox SX models are used as inferior vena cava filters to prevent pulmonary embolism in patients at risk of thromboembolic events.

What specialties typically use this device?

Interventional radiologists and vascular surgeons typically use IVC filters like the Synox SX models.

What are the FDA-cleared indications?

The FDA-cleared indications include preventing pulmonary embolism in patients who cannot receive anticoagulation therapy or have recurrent venous thromboembolism.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you